Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label DDI Study of SK-0403 and Metformin in Japanese Male Patients With Type 2 Diabetes Mellitus
jRCT2080221200Phase 3
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of anagliptin in type 2 diabetes mellitus (T2DM), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd. Primary endpoints: Pharmacokinetics of metformin with SK-0403 co-administration, Pharmacodynamics of metformin with SK-0403 co-administration and 1 more.
02
Drugs
anagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080221200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221200.